Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil

BACKGROUND: Since January 2017, the recommended first-line antiretroviral regimen in Brazil is the fixed-dose combination of tenofovir plus lamivudine with dolutegravir (TL + D). According to the literature, integrase resistance-associated mutations (INRAMs) are rarely found upon virologic failure t...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz, Ricardo Sobhie, Hunter, James R., Camargo, Michelle, Dias, Danilo, Galinskas, Juliana, Nassar, Isabela, de Lima, Isaac Barbosa, Caldeira, Debora Bellini, Sucupira, Maria Cecilia, Schechter, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210384/
https://www.ncbi.nlm.nih.gov/pubmed/37226112
http://dx.doi.org/10.1186/s12879-023-08288-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210384/
https://www.ncbi.nlm.nih.gov/pubmed/37226112
http://dx.doi.org/10.1186/s12879-023-08288-8

Ejemplares similares